Last reviewed · How we verify

NCT04645745

Myo-inositol, Alpha-Lactalbumin and Folic Acid Treatment in PCOS

Completed NA Last updated 14 January 2021
What this trial tests

NA trial testing myo-inositol, alpha-lactalbumin, folic acid in Polycystic Ovary Syndrome in 36 participants. Completed in 28 February 2020.

Timeline
15 June 2019
Primary endpoint
31 January 2020
28 February 2020

Quick facts

Lead sponsorAGUNCO Obstetrics and Gynecology Centre
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment36
Start date15 June 2019
Primary completion31 January 2020
Estimated completion28 February 2020
Sites2 locations across Italy, Mexico

Drugs / interventions tested

Conditions studied

Sponsor

AGUNCO Obstetrics and Gynecology Centre — full company profile →

Who can join

Adults 18 to 40, female only, with Polycystic Ovary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of this study is to evaluate the effect of myo-inositol and alpha-lactalbumin treatment on HOMA-index improvement in two different groups of women, belonging to the Mexican and Italian population, both affected by Polycystic Ovary Syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Polycystic Ovary Syndrome

Currently open trials in the same condition.

Other AGUNCO Obstetrics and Gynecology Centre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04645745.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing